Skip to main content
. 2014 May-Jun;21(3):176–180. doi: 10.1155/2014/965479

TABLE 4.

Secondary outcomes

Outcome CVVH (n=94) CVVHDF (n=59) P*
Glucocorticoids, n (%) 34 (36) 34 (58) <0.01
Lactate clearance, mmol/L, mean ± SD
  Day 1 −0.86±5.52 −1.43±4.23 0.52
  Day 2 −2.19±6.09 −1.24±4.04 0.33
Thyroid replacement, n (%) 16 (17) 23 (39) <0.01
*

χ2 test for categorical data and two-group t test for continuous data. CVVH Continuous venovenous hemofiltration; CVVHDF Continuous venovenous hemodiafiltration